To further investigate whether ZFP36L1 is induced by LSD1 inhibitors in SCLC preclinical models in vivo, we interrogated a publicly available RNA-seq dataset of SCLC patient-derived xenograft (PDX) models that were treated with ORY-1001 and displayed a variable response to ORY-10017. This evidence concerns the gene KDM1A and small cell lung carcinoma.